Owner Janssen Pharmaceutica NV

Inventors Coats, Steven J.; Zhang, Yue-mei; Lin, Shu-chen; Liu, Li; Miskowski, Tamara A.; Dax, Scott L.; Breslin, Hank; De Corte, Bart L.; He, Wei

Agent Shelston IP

Pub. Number AU-A-2010313397

PCT Pub. Number WO2011/053701

Priority 61/256,394 30.10.09 US

Filing date 28 October 2010

Wipo publication date 5 May 2011

C07D 239/28 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

C07D 239/34 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 413/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms

C07D 417/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group